Niki Papapostolou

ORCID: 0000-0003-3950-3089
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Allergic Rhinitis and Sensitization
  • Urticaria and Related Conditions
  • Asthma and respiratory diseases
  • Drug-Induced Adverse Reactions
  • Mast cells and histamine
  • Food Allergy and Anaphylaxis Research
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Dermatology and Skin Diseases
  • Inhalation and Respiratory Drug Delivery
  • Contact Dermatitis and Allergies
  • Respiratory and Cough-Related Research
  • Digital Mental Health Interventions
  • Autoimmune Bullous Skin Diseases
  • Click Chemistry and Applications
  • Pharmacovigilance and Adverse Drug Reactions
  • Complementary and Alternative Medicine Studies
  • Ferrocene Chemistry and Applications
  • Sinusitis and nasal conditions
  • Blood disorders and treatments
  • Health and Medical Studies

National and Kapodistrian University of Athens
2022-2024

University General Hospital Attikon
2023-2024

ENT and Allergy
2024

University of Aberdeen
2024

Atopic dermatitis (AD) is a recurrent, chronic, inflammatory, itchy skin disorder that affects up to 20% of the pediatric population and 10% adult worldwide. Onset typically occurs early in life, although cardinal disease features are similar across all ages, different age groups ethnicities present distinct clinical characteristics. The imposes significant burden health-related quality life domains, both children adults, substantial economic cost at individual national levels....

10.31083/j.fbl2902084 article EN cc-by Frontiers in Bioscience-Landmark 2024-02-22
Emek Kocatürk Pascale Salameh Esra Saraç Carolina Elisa Vera Ayala Simon Francis Thomsen and 95 more Torsten Zuberbier Luís Felipe Ensina Todor A. Popov Martijn B. A. van Doorn Ana M. Giménez‐Arnau Riccardo Asero Paulo Ricardo Criado Fernando Monteiro Aarestrup Zainab AbdulHameed Ansari Salma Al Abri Mona Al‐Ahmad Bushra Al Hinai Anastasiia Allenova Maryam Al‐Nesf Sabine Altrichter Rand Arnaout Joanna Bartosińska Andréa Carla Bauer Jonathan A. Bernstein Mojca Bizjak Hanna Bonnekoh Laurence Bouillet Zenon Brzoza Ana Caroline Calvalcanti Dela Bianca Melo Fernanda Lugão Campinhos Emily Carne Saleema Purayil Iván Chérrez-Ojeda Herberto José Chong‐Neto George Christoff Niall Conlon Roberta Fachini Jardim Criado Klara Cvenkel Ebru Damadoğlu I V Danilycheva Cascia Day Laurence de Montjoye Semra Demir Silvia Mariel Ferucci Daria Fomina Atsushi Fukunaga Elizabeth Garcia Aslı Gelincik J. Göbel Kiran Godse Margarida Gonçalo Maia Gotua Clive Grattan Agata Gugala Carole Guillet Alı Fuat Kalyoncu Gül Karakaya Alicja Kasperska−Zając Constance H. Katelaris Maryam Khoshkhui Andreas Kleinheinz Marta Kołacińska-Flont Pavel Kolkhir Mitja Košnik Dorota Krasowska Muthu Sendhil Kumaran Izabela Kupryś‐Lipińska Marcin Kurowski Elizaveta V. Kuznetsova Désirée Larenas‐Linnemann Marina S. Lebedkina Young‐Soo Lee Michaël Makris René Maximiliano Gómez Iman Nasr Sophia Neisinger Yoshiko Oda Rabia Öztaş Kara Esther Bastos Palitot Niki Papapostolou Claudio Alberto Salvador Parisi David Pesqué Jonny Peter Elena Petkova Katie Ridge Michael Rudenko Krzysztof Rutkowski Sarbjit S. Saini Andaç Salman Jorge Sánchez Bülent Enis Şekerel Sofia A. Serdotetskova Faradiba Sarquis Serpa Bahar Sevimli Dikicier Nikitas Sidiropoulos Agnieszka Sikora Jennifer Astrup Sørensen A. Soria Özlem Su Sherin Thalappil

10.1016/j.jaci.2023.07.019 article EN Journal of Allergy and Clinical Immunology 2023-08-12

Respiratory allergic diseases, affect over 500 million people globally and pose a substantial burden in terms of morbidity, mortality, healthcare costs. Restrictive factors such as geographical disparities, infectious pandemics, limitations resource, shortage allergy specialists underserved areas, impede effective management. Moreover, the well-established suboptimal adherence patients with respiratory allergies, contribute further to accelerated loss disease control.
 Telemedicine...

10.20944/preprints202401.1018.v1 preprint EN 2024-01-12

Respiratory allergic diseases affect over 500 million people globally and pose a substantial burden in terms of morbidity, mortality, healthcare costs. Restrictive factors such as geographical disparities, infectious pandemics, limitations resources, shortages allergy specialists underserved areas impede effective management. Telemedicine encompasses real-time visits, store-and-forward option triage, computer-based technologies for establishing efficient doctor-patient communication. Recent...

10.3390/jcm13030898 article EN Journal of Clinical Medicine 2024-02-04

Acute Localized Exanthematous Pustulosis (ALEP) is a rare skin reaction characterized by the sudden onset of multiple, small, sterile, non-follicular pustules in an erythematous and edematous base succeeding systemic drug administration. ALEP considered subtype Generalized (AGEP), although exact pathogenic mechanism disease remains poorly defined. Numerous drugs have been implicated pathogenesis ALEP, while contact mechanisms also reported. Herein, we describe first case attributed to...

10.3390/jcm12030831 article EN Journal of Clinical Medicine 2023-01-20

Angiotensin-converting enzyme (ACE) inhibitors are used primarily in the treatment of hypertension, heart failure, and acute phase myocardial infarction. Lisinopril [N2-[(1S)-1-car-boxy-3-phenylpropyl]-L-lysyl-L-proline], enalapril [(S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline] ramipril [2-aza-bicyclo-[3.3.0]-octane-3-carboxylic acid] all five-membered heterocycles three most prevalent ACE clinical use worldwide. 
 ACEi-induced angioedema (ACEi-AE) is clinically...

10.20944/preprints202402.0153.v1 preprint EN 2024-02-02

Fixed drug eruption (FDE) is a well-recognized, non-immediate, hypersensitivity reaction, often attributed to the use of various medications, most commonly non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics. Cross-reactivity between related NSAIDs in FDE has been reported, but among chemically unrelated NSAIDs, rare. Herein, we present rare well-documented case where patient initially displayed tolerance etoricoxib after experiencing nimesulide-induced FDE. Subsequently,...

10.3390/jcm13061583 article EN Journal of Clinical Medicine 2024-03-10

Beta-lactam (BL) antibiotics are among the most prescribed groups of drugs worldwide and have been implicated in a variety allergic reactions. There is paucity literature regarding patient adherence to instructions following comprehensive allergy assessments. The objective was follow up clinical course BL patients who underwent thorough allergological investigation for suspected at tertiary hospital ascertain patients' compliance with provided written instructions. An observational study...

10.3390/jpm13121719 article EN Journal of Personalized Medicine 2023-12-17

Angiotensin-converting enzyme (ACE) inhibitors are used primarily in the treatment of hypertension, heart failure, and acute phase myocardial infarction. Lisinopril [N2-[(1S)-1-car-boxy-3-phenylpropyl]-L-lysyl-L-proline], enalapril [(S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline] ramipril [2-aza-bicyclo-[3.3.0]-octane-3-carboxylic acid] all five-membered heterocycles three most prevalent ACE clinical use worldwide. inhibitor-induced angioedema (AE) is clinically...

10.3390/ph17030360 article EN cc-by Pharmaceuticals 2024-03-10

Aim: This study aims at assessing dupilumab’s response in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and its impact on concurrent mild to moderate asthma. Methods: The involved severe, uncontrolled CRSwNP patients starting dupilumab treatment (300 mg/2 weeks) the Allergy unit University General Hospital “Attikon” Athens, Greece, from May 2020 July 2022. Assessments were conducted baseline (week 0) weeks 2, 4, 16, 24, 52, covering 22-item Sino-Nasal Outcome Test (SNOT22), blood...

10.37349/eaa.2024.00039 article EN cc-by 2024-06-06
Coming Soon ...